598 related articles for article (PubMed ID: 30711478)
21. Efficacy and Safety of Tadalafil Once-a-Day versus Tadalafil On-Demand in Patients with Erectile Dysfunction: A Systematic Review and Meta-Analyses.
Peng Z; Yang L; Dong Q; Wei Q; Liu L; Yang B
Urol Int; 2017; 99(3):343-352. PubMed ID: 28628914
[TBL] [Abstract][Full Text] [Related]
22. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis.
Limoncin E; Gravina GL; Corona G; Maggi M; Ciocca G; Lenzi A; Jannini EA
Andrology; 2017 Sep; 5(5):863-872. PubMed ID: 28787547
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase-5 inhibitors could be efficacious in the treatment of erectile dysfunction after radiotherapy for prostate cancer: a systematic review and meta-analysis.
Yang L; Qian S; Liu L; Pu C; Yuan H; Han P; Wei Q
Urol Int; 2013; 90(3):339-47. PubMed ID: 23221333
[TBL] [Abstract][Full Text] [Related]
24. Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials.
Mulhall JP; Brock GB; Glina S; Baygani S; Donatucci CF; Maggi M
J Sex Med; 2016 May; 13(5):843-51. PubMed ID: 27017071
[TBL] [Abstract][Full Text] [Related]
25. Intraurethral alprostadil for erectile dysfunction: a review of the literature.
Costa P; Potempa AJ
Drugs; 2012 Dec; 72(17):2243-54. PubMed ID: 23170913
[TBL] [Abstract][Full Text] [Related]
26. Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis.
Kallidonis P; Adamou C; Kotsiris D; Ntasiotis P; Verze P; Athanasopoulos A;
Eur Urol Focus; 2020 May; 6(3):537-558. PubMed ID: 31133414
[TBL] [Abstract][Full Text] [Related]
27. Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy.
Mydlo JH; Volpe MA; Macchia RJ
Eur Urol; 2000 Jul; 38(1):30-4. PubMed ID: 10859438
[TBL] [Abstract][Full Text] [Related]
28. An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy.
Bai WJ; Li HJ; Dai YT; He XY; Huang YR; Liu JH; Sorsaburu S; Ji C; Jin JJ; Wang XF
Asian J Androl; 2015; 17(1):61-7. PubMed ID: 25370206
[TBL] [Abstract][Full Text] [Related]
29. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
30. New treatment options for erectile dysfunction in patients with diabetes mellitus.
Basu A; Ryder RE
Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
[TBL] [Abstract][Full Text] [Related]
31. Simplified Interpretation of the Erectile Function Domain of the International Index of Erectile Function.
Cappelleri JC; Tseng LJ; Luo X; Stecher V; Lue TF
J Sex Med; 2016 Apr; 13(4):690-6. PubMed ID: 26936074
[TBL] [Abstract][Full Text] [Related]
32. PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction.
Labairu-Huerta L; Padilla-Fernández B; Arrondo-Arrondo JL; Valverde-Martínez LS; Martín-Rodríguez A; Silva-Abuín JM; García-Cenador MB; Mirón-Canelo JA; Lorenzo-Gómez MF
Arch Ital Urol Androl; 2015 Sep; 87(3):204-9. PubMed ID: 26428641
[TBL] [Abstract][Full Text] [Related]
33. Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.
Kitrey ND; Gruenwald I; Appel B; Shechter A; Massarwa O; Vardi Y
J Urol; 2016 May; 195(5):1550-1555. PubMed ID: 26694904
[TBL] [Abstract][Full Text] [Related]
34. Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction in Diabetic Patients.
Spivak L; Shultz T; Appel B; Verze P; Yagudaev D; Vinarov A
Sex Med Rev; 2021 Oct; 9(4):619-627. PubMed ID: 31378506
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of intraurethral alprostadil in patients with erectile dysfunction refractory to treatment using phosphodiesterase-5 inhibitors.
Garrido Abad P; Sinués Ojas B; Martínez Blázquez L; Conde Caturla P; Fernández Arjona M
Actas Urol Esp; 2015 Dec; 39(10):635-40. PubMed ID: 26049734
[TBL] [Abstract][Full Text] [Related]
36. P144, A TGF-β1 antagonist peptide, synergizes with sildenafil and enhances erectile response via amelioration of cavernosal fibrosis in diabetic rats.
Li WJ; Wang H; Zhou J; Li B; Zhang J; Lu M; Wang Z
J Sex Med; 2013 Dec; 10(12):2942-51. PubMed ID: 24134744
[TBL] [Abstract][Full Text] [Related]
37. PDE5 inhibitors: considerations for preference and long-term adherence.
Smith WB; McCaslin IR; Gokce A; Mandava SH; Trost L; Hellstrom WJ
Int J Clin Pract; 2013 Aug; 67(8):768-80. PubMed ID: 23869678
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
39. Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System.
Salmasi A; Lee GT; Patel N; Goyal R; Dinizo M; Kwon YS; Modi PK; Faiena I; Kim HJ; Lee N; Hannan JL; Kohn J; Kim IY
J Sex Med; 2016 Dec; 13(12):1834-1843. PubMed ID: 27843073
[TBL] [Abstract][Full Text] [Related]
40. Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction.
Yafi FA; Sharlip ID; Becher EF
Sex Med Rev; 2018 Apr; 6(2):242-252. PubMed ID: 28923561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
